Details of the Drug

General Information of Drug (ID: DM5FHUP)

Drug Name

RP103

Synonyms

Cysteamine bitartrate; UNII-QO84GZ3TST; QO84GZ3TST; CYSTEAMINE BITARTRATE; Procysbi; Procysbi (TN); EINECS 248-641-7; Cysteamine bitartrate (JAN); beta-Mercaptoethylamine bitartrate; AKOS032954217; beta-Mercaptoethylamine hydrogen tartrate; D10468; Ethanethiol, 2-amino-, tartrate (1:1) (salt)

Indication

Disease Entry	ICD 11	Status	REF
Huntington disease	8A01.10	Phase 2/3	[1]

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C6H13NO6S
Canonical SMILES: C(CS)N.C(C(C(=O)O)O)(C(=O)O)O
InChI: InChI=1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/m1./s1
InChIKey: NSKJTUFFDRENDM-ZVGUSBNCSA-N

Cross-matching ID

PubChem CID: 11958147
CAS Number: 27761-19-9
TTD ID: D0VD6Q

Drug-Molecule Activity Atlas (DMA)^NEW

Click to Jump to the Detailed DMA Information of This Drug

Drug ADMET Endpoint Profile (DAE)^NEW

Click to Jump to the Detailed DAE Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)